Novo Nordisk reported DKK33.8B in Pre-Tax Profit for its fiscal quarter ending in June of 2025.





Pre Tax Profit Change Date
Bausch Health Companies USD 348M 1.7B Jun/2026
Bristol-Myers Squibb USD 4.99B 1.75B Jun/2026
Eli Lilly USD 8.85B 583.8M Mar/2026
GlaxoSmithKline GBP 2.68B 532M Jun/2026
Merck USD -3.53B 6.95B Mar/2026
Novartis USD 4.27B 430M Jun/2026
Novo Nordisk DKK 33.8B 3.23B Jun/2025
Novo Nordisk DKK 62.17B 36.66B Mar/2026
Pacira USD 5M 4.43M Mar/2026
Sanofi EUR 837M 1.17B Jun/2026
Supernus Pharmaceuticals USD -57.65M 51.7M Jun/2026